One audit, five markets: is MDSAP right for your roadmap?

The Medical Device Single Audit Program lets one audit satisfy five regulators: the United States FDA, Health Canada, Australia's TGA, Brazil's ANVISA, and Japan's MHLW and PMDA. That is a real efficiency, but efficiency only counts when it matches where your company is actually going. The right question is not whether MDSAP is good. It is whether MDSAP fits your roadmap.

How the single audit works

Under MDSAP, an authorized Auditing Organization conducts one audit against ISO 13485 and the specific regulatory requirements of the five participating authorities. The resulting audit report is then recognized by each of those regulators, on a predictable multi-year cycle, in place of the separate audits or inspections they would otherwise run. One well-run audit does the work that used to mean several.

Where it is required, and where it is accepted

The programs are not identical in how they treat MDSAP, and that difference drives the decision:

• Canada requires it. Health Canada uses MDSAP as the basis for medical device licensing, so if Canada is on your map, MDSAP is effectively mandatory.
• The FDA accepts it in place of most routine inspections, which can reduce your inspection exposure in the United States.
• Australia, Brazil, and Japan recognize MDSAP within their own market authorization processes to varying degrees.

When MDSAP is the right call

MDSAP earns its keep when more than one of these markets sits in your two to three year plan, and it becomes close to non-negotiable the moment Canada is one of them. For a company already carrying ISO 13485, the incremental effort to reach MDSAP readiness is manageable, and the payoff is a single, planned audit rhythm instead of a scattered set of them.

When it is more program than you need

If you sell only in the United States, or you are pre-market and early enough that none of these markets are on a realistic near-term horizon, MDSAP can be more overhead than value today. There is no prize for certifying to markets you are not pursuing. In that case, keep a clean ISO 13485 foundation and revisit MDSAP when your commercial roadmap actually reaches one of the five.

Map your markets first. MDSAP is an accelerator for a roadmap you already have, not a substitute for having one.

Back to Insights